FREE ESSAY ON BRIEF REVIEW OF PLATINUM'S MEDICAL PRODUCTS AND THE ADDITIONAL FUNDING REQUIRED

BRIEF REVIEW OF PLATINUM'S MEDICAL PRODUCTS AND THE ADDITIONAL FUNDING REQUIRED

PlatiNUM Medical, Inc.
Brief Review of PlatiNUM's Medical Products and the Additional Funding Required
Prepared for
Greg Krel
Chief Investment Officer
Westwood Ventures
Irvine, California
Prepared by
Andrew S. McAlister, CEO, Co-Founder
Jason J. Smith, Senior Vice President, Co-Founder
December 6, 1999
TO: Mr. Greg Krel, Chief Investment Officer
FROM: Andrew S. , Chief Executive Officer, Co-Founder
Jason J. , Senior Vice President, Co-Founder
DATE: December 6, 1999
SUBJECT: Report on purpose of additional funding required for future development of
PlatiNUM Medical, Inc.
This is the report on the latest cardiovascular medical device that you requested on
November 17, 1999.
This report discusses in explicit detail how we came to develop such an effective device.

The research and study methods, which were used, will be introduced. We met with
Doctors and patients in order to get accurate details from both parties. These surveys
were conducted in both the United States and in several European Nations. As you can
see, we have studied all angles, and have developed a product superior to our 
competitors. 
Our device, the "PlatiNUM Device" offers the best in medical technology. PlatiNUM's 
development involved taking the best of other procedures and rolling it into
one multipurpose device. While eliminating the bad possibilities, which could occur with

other methods.
Thank you for taking the time to read our proposal and allowing PlatiNUM the chance to
further benefit the world with safer, more effective medical technology. On behalf of
PlatiNUM Medical, Inc. and all of our staff we are confident that this report will 
convince you to make the right choice, and help put an end to the suffering of the 
millions of people with heart disease.
jsm
Attachment
ii
CONTENTS
Executive Summary ................................................... iv
Introduction ............................................................ 1
Purpose for Research ........................................ 1
Methods and Procedures Used .............................. 1
Problems Which Frequently Occur ................................. 2
Benefits of having the PlatiNUM Device ................. 2
Legal Considerations in Marketing .................................. 2
Market Potential ....................................................... 3
Summary ....................................................... 3
Forecast for PlatiNUM Over the Next 2 Years .................... 4
Summary ....................................................... 4
Conclusion .............................................................. 5
Recommendations ...................................................... 5
References ............................................................... 6
iii
EXECUTIVE SUMMARY
PlatiNUM Medical, Inc. was founded in 1995 and is located in Irvine, California,
centrally located in one of the leading medical device development areas in the country.
Our company is the leader in the development of a new type of medical device for treating
cardiovascular disease, also known as heart disease. Despite on going efforts to combat
this disease, no other promising instruments have been introduced. The need still remains
for a device that can easily and safely remove dangerous tissues found in the arteries
and other problems associated with the heart.
Through the past four years PlatiNUM has conducted research in the U.S. as well as
Europe. Surveys and interviews were held with leading cardiovascular physicians to
determine the best features for the device. When this process was completed, we then took
the next step, which involved patient surveys and gathered input on what they thought was
needed. Although our research and data collecting will never end, the past four years has
given us the specifications, which must be met in the product that we developed. 
Our research has led to the following: (1) A device, which eliminates all possible
complications, associated with heart disease today. (2) Something that would not be as
dangerous and risky as By-pass surgery. (3) A device which is simple to use and requires
no additional training. (4) Finally, a device which is affordable, and efficient. 
PlatiNUM has developed a device that meets and exceeds all of these strict standards. The
PlatiNUM device with our patented "Omni Cutter" does the trick. Hopefully, in the near
future the citizens of the world who suffer from heart disease will be fortunate to have
this device available.
Physician Comments about the PlatiNUM device:
"Best device ever for treating Heart Disease"
Thomas Ischeinger, MD
"Best device ever for Failed Bypass"
David Cox, MD
"Incredibly easy to set up and use......
adoption will be fast"
Gregg Stone, MD
iv
DISCUSSION ON THE ISSUE OF PREVENTING HEART DISEASE AND COMPLICATIONS
Introduction
Heart problems are a way of life for many Americans throughout the nation. Whether it is
heredity, our diets, or some other cause. Heart disease and related problems kill 10
million Americans annually with numbers on the rise. With these skyrocketing numbers, it
shows that something needs to be done about this horrible condition. Fatality rates due
to heart disease need to come down, and the millions of Americans who suffer from these
problems deserve to lead happier, healthier lives. The methods used today are drastically
failing and do not have promising success rates. Highly respected medical physicians such
as Dr. Thomas Ischeinger, Dr. David Cox, and Dr. Gregg Stone will tell you the same. This
is why PlatiNUM felt the need to develop a new, safer device. A device that will
drastically bring down the fatality rates involved with heart disease.
Purpose for the Research:
The purpose for our research was to develop a device, which rose above the standards of
all the others. One that eliminated all of the negative side effects of the competitors,
and incorporated many of the good features of the others. Not only the helpful aspects of
the others, but many new aspects as well. Most importantly above all else is the
continued research to get FDA approval in order for this device to be used in the United
States. Answers were sought to the following questions.
1. What are the current problems associated with heart disease treatment today?
2. What should our device be designed to do?
3. What legal issues are raised regarding the use of this device?
4. Why would this device be such a success?
Methods and Procedures Used:
Most of the information and data collected was gathered through the countless surveys and
interviews conducted in both Europe and in the U.S. Our staff visited numerous, highly
specialized medical officials, each one at the top of their field. We asked them their
opinions, and what they would like to see in a new product. We then hit the books,
researching the leading causes in heart disease treatment failures, and tried to
determine that went wrong and why.
1
2
Problems Which Frequently Occur:
Bypass surgery, which is the surgical procedure most historically, conducted is extremely
risky. 20 percent fail within the first year and more than 50 percent within 10 years.
Because of the high risk of the surgery many go untreated. Another problem involves the
use of Stents. Stents are small tube like instruments, which are designed to maintain a
normal bloodstream. Well, 20-25 percent of these cases fail within the first 6 months. As
small as it is these are primarily the only treatments currently being used and the
problems which go along with them.
Benefits of having the PlatiNum device:
Our device eliminates all the problems I just mentioned. The PlatiNum device surpasses
all competition and all of those medical professionals who use it, will love it. The
PlatiNum device removes dangerous clots in the arteries caused from massive tissue blocks
or by the procedures I mentioned before. With PlatiNum's patented "Omni cutter" we can
now treat diseased coronary arteries. By positioning this cutter at the tip of what's
called a catheter, a powerful force is created bringing dangerous, occlusive tissue into
the catheter. This junk is than removed by vacuum from the blood vessel. No major surgery
needed and completely safe. So far from the news in Europe all is going well. Another
benefit is the way the device is packaged. It comes is a simple, disposable unit. For
doctors this is a tremendous convenience. This device comes fully assembled and is easy
to use. I believe this device pretty much sells itself, all we need is to get this
wonderful product available in the U.S.
Legal Considerations in Marketing:
Many considerations for the use of a medical device must be met to ensure product safety.
Governmental agencies were established to set the standards and guidelines for the
quality and use of medical devices in humans. As with the United States and the FDA or
Food and Drug Administration, Europe has its agency known as CE Mark, a review board made
up of doctors and insurance representatives which meet and review the safety and
applications of such medical devices and procedures. Approval by CE Mark was made earlier
this year, with FDA approval just around the corner. As with all approval agencies, the
burden of safety falls on the product. With the impressive safety records PlatiNUM has
established, we see no reason for postponement of the FDA approval next fall.
3
Market Potential:
Summary:
This diagram illustrates the market potential, which can be reached by the PlatiNUM
device within the next 2-3 years. As you can see, there is enormous market potential for
PlatiNUM Medical to grow into in the future years.
4
Forecast for PlatiNUM over the next 2 years:
Summary:
This graph illustrates the profits and revenues forecasted for the next 2 years at
PlatiNUM. As you can see in 1998 the company was a small purely involved in its research
and development phase. In 1999, PlatiNUM began to expand, introducing a clean room
facility for product assembly, which can later be used for manufacturing. In late 1999 CE
Mark approval was granted, and PlatiNUM began gearing up for European exporting. By early
2000, the first major profits will show from the European market. By late 2000, FDA
approval should be granted, and PlatiNUM's facilities will gear up for major production
of its device for use in the American market, revenues will exceed 10 million dollars and
the company will begin to liquidate debt and show profits. By 2002, PlatiNUM will be
common practice in nearly all heart disease cases; we will have revolutionized the
medical industry.
5
Conclusion:
PlatiNUM Tips & Tricks:
6
REFERENCES
EndiCOR Medical, Inc. Newsletter, Volume 6(15 November 1999) Responding to Issues of
Interventional Cardiology with the X-Sizer.
David D. Gutterman, MD. Professor of Cardiovascular Medicine, Medical College of
Wisconsin, Cardiovascular Research Center (12 November 1999) Heart Disease Can Be a
Silent Killer [On-Line] Available http://healthlink.mcw.edu/article/942430653.html [1999
November 29]
National Institutes of Health (12 July, 1999) Heart Failure Treatments [On-Line]
Available http://healthlink.mcw.edu/article/931814766.html [1999 November 29]
Karen A. Matthews, Ph.D., University of Pittsburgh School of Medicine (September 18,
1998) Suppressed Anger Increases Heart Disease in Both Men and Women [On-Line] Available
http://mentalhelp.net/articles/anger2.htm [1999 November 27]
Encyclopedia.com, Heart Disease [On-Line] Available
http://www.encyclopedia.com/articles/05744.html [1999 November 27]
World Medical Manufacturing Corp. Talent Stent-Graft System [On-Line] Available
http://www.worldmedical.com/booklet/contents.htm [1999 November 28]
FDA / Center for Food Safety & Applied Nutrition. Biotechnology [On-Line] Available
http://vm.cfsan.fda.gov/~lrd/biotechm.html [1999 November 28]
Cardiothoracic Surgery of Savannah. Advances in Open Heart Surgery (February 14,1999)
[On-Line] Available http://www.openheartsurgery.com/ [1999 November 28]